Cause of Familial Testicular Cancer
NCT00034424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 749
Last updated 2026-04-17
Summary
Background:
People with a family history of testicular cancer may be at increased risk for the disease.
Genetic and clinical studies of patients with testicular cancer and their family members may help clarify the cause of the disease and identify clinical features.
Objectives:
To characterize the clinical features of testicular cancer.
To identify genes that may lead to increased risk of the disease.
To examine emotional and behavioral issues of members of families at increased risk of the disease.
Eligibility:
Males and females from a family with at least two cases of testicular cancer in blood relatives.
Males with testicular cancer in both testicles.
Males with testicular cancer who have an identical twin.
Participants must be at least 12 years of age.
Design:
Participants may take part in Part 1 or Parts 1 and 2 of this 2-part study.
Part 1 participants:
* Provide a blood or cheek cell sample to obtain DNA for gene studies.
* Provide permission for researchers to obtain their medical records for review.
* Complete questionnaires about their personal and family medical history, exposure to factors that might influence the risk of testicular cancer, and their feelings about being a member of a family in which several members have testicular cancer.
* These data are collected from participants in their home communities.
Part 2 participants:
* All participants provide a medical history, have a complete physical examination, including routine lab tests, and have an ultrasound test of the abdomen to look at the kidneys.
* Males have an ultrasound test of the testicles and scrotum.
* Females have an ultrasound test of the pelvis to look at the ovaries, uterus and fallopian tubes.
* Males 18 years of age and older provide a semen sample.
* Some participants have computed tomography (CT) scanning of the chest, abdomen and pelvis instead of kidney ultrasound. Children under 18 years of age may have magnetic resonance imaging (MRI) instead of CT.
* These data are collected from participants during a 2-day visit to the NIH Clinical Center in Bethesda, MD. Travel costs are covered by the protocol.
Conditions
- Testicular Cancer
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Douglas R Stewart, M.D. · National Cancer Institute (NCI)
Eligibility
- Min Age
- 12 Years
- Max Age
- 77 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-13
Countries
- United States
Study Locations
More Related Trials
-
Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk
NCT00820287 ·Status: TERMINATED ·Phase: NA
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
NCT00039676 ·Status: ACTIVE_NOT_RECRUITING
-
DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
NCT01434355 ·Status: COMPLETED
-
Germ Cell Tumor and Testicular Tumor DNA Registry
NCT02099734 ·Status: RECRUITING
-
Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
NCT00341757 ·Status: COMPLETED
-
Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
NCT01572467 ·Status: COMPLETED
-
Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells
NCT00020072 ·Status: COMPLETED ·Phase: NA
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
NCT01109420 ·Status: RECRUITING
-
Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples
NCT00001814 ·Status: COMPLETED
-
Exploratory Study of Molecular Characterization in Patients With Metastatic Germ Cell Tumours Refractory/Resistant to Platinum Treatment
NCT03980587 ·Status: UNKNOWN
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
NCT06564428 ·Status: RECRUITING
-
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members
NCT00346008 ·Status: COMPLETED
-
Molecular Genetics Studies of Cancer Patients and Their Relatives
NCT04185935 ·Status: RECRUITING
-
A Follow-up Study of Women Evaluated and Treated for Infertility
NCT00342446 ·Status: COMPLETED
-
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
NCT04257045 ·Status: COMPLETED
-
Physicians Survey on Genetic Testing
NCT00341107 ·Status: COMPLETED
-
Family Study of Head and Neck Cancers in Taiwan
NCT00342147 ·Status: COMPLETED
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
NCT03030404 ·Status: COMPLETED
-
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families
NCT03119285 ·Status: COMPLETED
-
MicroRNA as Markers in Testicular Cancer
NCT04914026 ·Status: RECRUITING
-
Hereditary Risk Factors for Thyroid Cancer
NCT02747888 ·Status: RECRUITING ·Phase: NA